Teva- Pharmaceutical Industries (TEVA) Income Statement (2017 - 2026)
Income Statement report data from Mar 31, 2017 to Mar 31, 2026 for Teva- Pharmaceutical Industries (TEVA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||||||||||
Total Revenue | 3.98B (-15.47%) | 4.71B (+5.16%) | 4.48B (+7.28%) | 4.18B (+7.32%) | 3.89B (-7.99%) | 4.23B (-2.38%) | 4.33B (+4.03%) | 4.16B (+9.03%) | 3.82B (-14.31%) | 4.46B (+15.77%) | 3.85B (-0.72%) | 3.88B (+5.93%) | 3.66B (-5.72%) | 3.88B (+8.01%) | 3.60B (-5.04%) | 3.79B (+3.41%) | 3.66B (-10.69%) | 4.10B (+5.45%) | 3.89B (-0.59%) | 3.91B (-1.81%) | 3.98B (-10.60%) | 4.45B (+11.97%) | 3.98B (+2.79%) | 3.87B (-11.18%) | 4.36B (+9.17%) | 3.99B (-6.40%) | 4.26B (-1.68%) | 4.34B (+0.98%) | 4.29B (+8.02%) | 3.98B (-12.21%) | 4.53B (-3.66%) | 4.70B (-7.19%) | 5.07B (+4.09%) | 4.87B (-13.37%) | 5.62B (-1.80%) | 5.72B (+1.24%) | 5.65B |
Gross Profit | 1.97B (-25.73%) | 2.65B (+15.23%) | 2.30B (+9.61%) | 2.10B (+11.99%) | 1.88B (-11.50%) | 2.12B (-1.26%) | 2.15B (+6.13%) | 2.02B (+14.29%) | 1.77B (-26.70%) | 2.42B (+30.52%) | 1.85B (+3.06%) | 1.80B (+13.53%) | 1.58B (-10.62%) | 1.77B (+6.05%) | 1.67B (-6.97%) | 1.79B (+3.10%) | 1.74B (-15.08%) | 2.05B (+14.21%) | 1.79B (-4.22%) | 1.87B (-0.27%) | 1.88B (-8.30%) | 2.05B (+10.58%) | 1.85B (+5.05%) | 1.76B (-14.54%) | 2.06B (+5.36%) | 1.96B (+6.99%) | 1.83B (-3.33%) | 1.89B (+1.99%) | 1.86B (-0.54%) | 1.87B (-7.67%) | 2.02B (-1.94%) | 2.06B (-12.22%) | 2.35B (+3.39%) | 2.27B (-14.30%) | 2.65B (-7.18%) | 2.85B (+0.56%) | 2.84B |
Operating Expenses | |||||||||||||||||||||||||||||||||||||
Research And Development | 222M (-16.54%) | 266M (+3.91%) | 256M (+4.92%) | 244M (-1.21%) | 247M (0.00%) | 247M (+2.92%) | 240M (-10.78%) | 269M (+11.16%) | 242M (+7.08%) | 226M (-10.67%) | 253M (+5.42%) | 240M (+2.56%) | 234M | -359.00M | 175M (-23.25%) | 228M (+322.22%) | 54M (-77.78%) | 243M (+9.46%) | 222M (-10.48%) | 248M (-2.36%) | 254M (-13.31%) | 293M (+13.57%) | 258M (+14.67%) | 225M (+1.81%) | 221M (-5.15%) | 233M (-2.92%) | 240M (-13.04%) | 276M (+5.75%) | 261M | -541.00M | 311M (+7.24%) | 290M (+437.04%) | 54M | -1.26B | 531M (+13.22%) | 469M (+8.56%) | 432M |
Selling General And Administrative | 304M (-17.39%) | 368M (+16.09%) | 317M (+3.93%) | 305M (+2.69%) | 297M (-1.66%) | 302M (+1.34%) | 298M (+5.30%) | 283M (+1.80%) | 278M (-4.47%) | 291M (+8.58%) | 268M (-12.70%) | 307M (+3.72%) | 296M (+2.78%) | 288M (+1.77%) | 283M (-9.58%) | 313M (+5.74%) | 296M (+7.25%) | 276M (-5.15%) | 291M (+20.25%) | 242M (-16.55%) | 290M (-11.04%) | 326M (+16.85%) | 279M (+5.68%) | 264M (-13.16%) | 304M (-4.70%) | 319M (+11.93%) | 285M (-3.72%) | 296M (+1.37%) | 292M (-15.12%) | 344M (+11.33%) | 309M (-2.22%) | 316M (-3.95%) | 329M (-6.00%) | 350M (-5.91%) | 372M (+2.48%) | 363M (-0.82%) | 366M |
Operating Expenses | 526M (-17.03%) | 634M (+10.65%) | 573M (+4.37%) | 549M (+0.92%) | 544M (-0.91%) | 549M (+2.04%) | 538M (-2.54%) | 552M (+6.15%) | 520M (+0.58%) | 517M (-0.77%) | 521M (-4.75%) | 547M (+3.21%) | 530M | -71.00M | 458M (-15.34%) | 541M (+54.57%) | 350M (-32.56%) | 519M (+1.17%) | 513M (+4.69%) | 490M (-9.93%) | 544M (-12.12%) | 619M (+15.27%) | 537M (+9.82%) | 489M (-6.86%) | 525M (-4.89%) | 552M (+5.14%) | 525M (-8.22%) | 572M (+3.44%) | 553M | -197.00M | 620M (+2.31%) | 606M (+58.22%) | 383M | -907.00M | 903M (+8.53%) | 832M (+4.26%) | 798M |
Depreciation And Amortization | 239M (-7.36%) | 258M (+3.61%) | 249M (-0.80%) | 251M (+2.87%) | 244M (-9.29%) | 269M (+3.86%) | 259M (0.00%) | 259M (-4.78%) | 272M (+2.26%) | 266M (-6.01%) | 283M (-5.67%) | 300M (-1.32%) | 304M (-0.65%) | 306M (-4.67%) | 321M (-10.34%) | 358M (+10.84%) | 323M (-66.14%) | 954M | - | - | 376M (-67.53%) | 1.16B | - | - | 399M (-68.80%) | 1.28B | - | - | 443M (-66.82%) | 1.33B | - | - | 507M (-68.93%) | 1.63B | - | - | 480M |
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Income | 652M (+116.61%) | 301M (-65.87%) | 882M (+93.85%) | 455M (-12.33%) | 519M | -29.00M (-43.14%) | -51.00M (+920.00%) | -5.00M (-97.71%) | -218.00M | 756M (+119.77%) | 344M | -654.00M (+4930.77%) | -13.00M (-98.64%) | -954.00M | 419M | -949.00M (+33.10%) | -713.00M | 77M (-87.64%) | 623M (+7.04%) | 582M (+34.10%) | 434M (+6.90%) | 406M | -4.34B | 173M (-9.42%) | 191M (+29.05%) | 148M | -81.00M (-87.42%) | -644.00M | 134M | -3.16B | 16M | -14.00M | 1.52B | -13.02B | 378M | -5.74B | 895M |
Ebit | 652M (+116.61%) | 301M (-65.87%) | 882M (+93.85%) | 455M (-12.33%) | 519M | -29.00M (-43.14%) | -51.00M (+920.00%) | -5.00M (-97.71%) | -218.00M | 756M (+119.77%) | 344M | -654.00M (+4930.77%) | -13.00M (-98.64%) | -954.00M | 419M | -949.00M (+33.10%) | -713.00M | 77M (-87.64%) | 623M (+7.04%) | 582M (+34.10%) | 434M (+6.90%) | 406M | -4.34B | 173M (-9.42%) | 191M (+29.05%) | 148M | -81.00M (-87.42%) | -644.00M | 134M | -3.16B | 16M | -14.00M | 1.52B | -13.02B | 378M | -5.74B | 895M |
EBITDA | 891M (+59.39%) | 559M (-50.57%) | 1.13B (+60.20%) | 706M (-7.47%) | 763M (+217.92%) | 240M (+15.38%) | 208M (-18.11%) | 254M (+370.37%) | 54M (-94.72%) | 1.02B (+63.00%) | 627M | -354.00M | 291M | -648.00M | 740M | -591.00M (+51.54%) | -390.00M | 1.56B (+324.73%) | 368M (+20.66%) | 305M (-62.35%) | 810M (-52.13%) | 1.69B | -4.33B | 36M (-93.90%) | 590M (-68.50%) | 1.87B | -303.00M (-65.09%) | -868.00M | 577M | -1.34B (+473.08%) | -234.00M (-7.14%) | -252.00M | 2.03B | -10.86B | 101M | -5.99B | 1.38B |
Other Income / Expenses | |||||||||||||||||||||||||||||||||||||
Interest Expense | - | 916M | - | - | - | 1.00B | - | - | - | 1.03B | - | - | - | 930M | - | - | - | 891M | - | - | - | 901M | - | - | - | 822M | - | - | - | 920M | - | - | - | 875M | - | - | - |
Net Interest Income | - | -916.00M | - | - | - | -1.00B | - | - | - | -1.03B | - | - | - | -930.00M | - | - | - | -891.00M | - | - | - | -901.00M | - | - | - | -822.00M | - | - | - | -920.00M | - | - | - | -875.00M | - | - | - |
Other Non Operating Income | -216.00M (-76.87%) | -934.00M (+294.09%) | -237.00M (-5.95%) | -252.00M (+12.00%) | -225.00M (-77.06%) | -981.00M (+260.66%) | -272.00M (+12.86%) | -241.00M (-3.60%) | -250.00M (-76.35%) | -1.06B (+277.50%) | -280.00M (+4.48%) | -268.00M (+3.08%) | -260.00M (-73.08%) | -966.00M (+283.33%) | -252.00M (+19.43%) | -211.00M (-18.22%) | -258.00M (-75.61%) | -1.06B (+339.00%) | -241.00M (-12.04%) | -274.00M (-5.52%) | -290.00M (-65.23%) | -834.00M (+612.82%) | -117.00M (-47.53%) | -223.00M (-0.45%) | -224.00M (-72.75%) | -822.00M (+289.57%) | -211.00M (+2.43%) | -206.00M (-5.50%) | -218.00M (-77.27%) | -959.00M (+318.78%) | -229.00M (-2.97%) | -236.00M (-12.92%) | -271.00M (-69.72%) | -895.00M (+245.56%) | -259.00M (+8.82%) | -238.00M (+14.98%) | -207.00M |
Net Income | |||||||||||||||||||||||||||||||||||||
Income Tax Expense | 67M | -390.00M | 214M | -78.00M | 74M (+155.17%) | 29M (-57.97%) | 69M (-89.05%) | 630M | -52.00M | 40M | -12.00M (-25.00%) | -16.00M (-15.79%) | -19.00M | 148M (+38.32%) | 107M | -900.00M | 2.00M | -25.00M | 76M (-22.45%) | 98M (+58.06%) | 62M | -21.00M | 16M | -104.00M (+76.27%) | -59.00M (-50.42%) | -119.00M | 11M | -179.00M | 9.00M | -139.00M (+434.62%) | -26.00M (-65.79%) | -76.00M | 46M | -1.47B (+197.77%) | -494.00M (+2145.45%) | -22.00M | 54M |
Net Income From Continuing Operations | 369M (-23.28%) | 481M (+11.09%) | 433M (+53.55%) | 282M (+31.78%) | 214M | -217.00M (-50.34%) | -437.00M (-48.35%) | -846.00M (+508.63%) | -139.00M | 464M (+572.46%) | 69M | -872.00M (+296.36%) | -220.00M (-83.27%) | -1.31B | 56M | -232.00M (-75.71%) | -955.00M (+500.63%) | -159.00M | 292M (+41.06%) | 207M (+168.83%) | 77M (-48.67%) | 150M | -4.35B | 140M (+102.90%) | 69M (-36.70%) | 109M | -314.00M (-54.43%) | -689.00M (+556.19%) | -105.00M (-96.36%) | -2.89B (+1287.50%) | -208.00M (+18.18%) | -176.00M | 1.12B | -11.54B | 595M | -5.97B | 645M |
Net Income | 369M (-23.28%) | 481M (+11.09%) | 433M (+53.55%) | 282M (+31.78%) | 214M | -217.00M (-50.34%) | -437.00M (-48.35%) | -846.00M (+508.63%) | -139.00M | 464M (+572.46%) | 69M | -872.00M (+296.36%) | -220.00M (-83.27%) | -1.31B | 56M | -232.00M (-75.71%) | -955.00M (+500.63%) | -159.00M | 292M (+41.06%) | 207M (+168.83%) | 77M (-48.67%) | 150M | -4.35B | 140M (+102.90%) | 69M (-36.70%) | 109M | -314.00M (-54.43%) | -689.00M (+556.19%) | -105.00M (-96.36%) | -2.89B (+1287.50%) | -208.00M (+18.18%) | -176.00M | 1.12B | -11.54B | 595M | -5.97B | 645M |
Comprehensive Income Net Of Tax | 248M (-88.56%) | 2.17B (+457.33%) | 389M (-26.19%) | 527M (-23.29%) | 687M | -2.09B (+543.83%) | -324.00M (-65.93%) | -951.00M (+344.39%) | -214.00M (-48.80%) | -418.00M (+154.88%) | -164.00M (-80.61%) | -846.00M (+907.14%) | -84.00M (-96.77%) | -2.60B (+775.42%) | -297.00M (-14.16%) | -346.00M (-63.92%) | -959.00M | 133M (+12.71%) | 118M (-60.00%) | 295M | -57.00M (-98.60%) | -4.08B (-4.94%) | -4.29B | 289M | -471.00M (-44.72%) | -852.00M (+132.15%) | -367.00M (-42.83%) | -642.00M (+12740.00%) | -5.00M (-99.82%) | -2.76B (+982.75%) | -255.00M (-65.02%) | -729.00M | 1.23B | -14.96B | 798M | -5.66B | 1.09B |